7148-34-7 Usage
Uses
Due to the limited information available on 4,8-dichloro-quinazoline, its applications are not well-defined. However, based on the general properties of quinazolines, it can be inferred that it may have potential uses in the following areas:
Used in Pharmaceutical Industry:
4,8-Dichloro-quinazoline could be used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Quinazolines are known to have a wide range of biological activities, and the presence of chlorine atoms in 4,8-DICHLORO-QUINAZOLINE may impart additional properties that could be exploited in drug development.
Used in Chemical Research:
4,8-Dichloro-quinazoline may be used as a research compound in academic or industrial laboratories to study the properties and reactivity of quinazolines. The presence of chlorine atoms could make it a useful probe for investigating the effects of halogenation on the chemical behavior of quinazoline derivatives.
Used in Material Science:
Although not explicitly mentioned, 4,8-dichloro-quinazoline may have potential applications in the development of new materials, such as organic semiconductors or optoelectronic devices, due to the electronic properties conferred by the quinazoline core and the chlorine substituents.
Check Digit Verification of cas no
The CAS Registry Mumber 7148-34-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,4 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7148-34:
(6*7)+(5*1)+(4*4)+(3*8)+(2*3)+(1*4)=97
97 % 10 = 7
So 7148-34-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H4Cl2N2/c9-6-3-1-2-5-7(6)11-4-12-8(5)10/h1-4H
7148-34-7Relevant academic research and scientific papers
POLAR QUINAZOLINES AS LIVER X RECEPTORS ( LXRS ) MODULATORS
-
Page/Page column 50, (2010/07/10)
Disclosed are polar quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): INSERT FORMULA HERE AS IT APPEARS IN WRITTEN FORM IN THE SPECIFICATION (I) in which, R1, R2, R3, R4, R5, R6,
Quinazoline Compounds
-
Page/Page column 36-37, (2010/12/26)
Disclosed are quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): in which R1, R2, R3, R4, R5, R6, R7,
